This study is the first cohort-based investigation to evaluate the association between bilirubin subtypes (total, indirect, and direct bilirubin) and thyroid cancer risk using the ALBI (Albumin-Bilirubin) and PALBI (Platelet-Albumin-Bilirubin) indices in a general population. Here, ALB is linked to thyroid gland carcinoma.